Search | Page 12 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. CD34+ Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation for Non-Malignant Disease

    ... to determine the time to neutrophil and platelet engraftment , to determine the time to immune ...

    Clinical Trial last updated 06/13/2016 - 2:06pm.

  2. New York Blood Center National Cord Blood Program

    ... is obtained to assess cord blood myeloid and platelet engraftment , transplant related mortality, overall ...

    Clinical Trial last updated 06/13/2016 - 1:43pm.

  3. EHA S826: Eltrombopag Added to Standard Immunosuppression as First Treatment in Severe Aplastic Anemia

    ... Eltrombopag (Promacta®) is a treatment that increases platelet counts and decreases bleeding risk. This phase 2 clinical ... at six months. Cohort 1 patients stopped needing platelet transfusions after a median 32 days of treatment. They stopped needing ...

    Research Review last updated 05/02/2016 - 9:10am.

  4. Clinical Utility of Lenalidomide in the Treatment of Myelodysplastic Syndromes

    ... are near this del(5q) region include those that affect platelet production. Furthermore, the entity of 5q-syndrome (which is ... Phase III study is underway now. A study combining platelet growth factors and lenalidomide preliminarily demonstrated decreased ...

    Research Review last updated 05/02/2016 - 9:12am.

  5. ASH 2012 - Reviewing MDS Progress from Research and Clinical Perspectives

    ... purpura (ITP). Patients with ITP have a low platelet count, not because of a bone marrow problem, but due to an ... earlier studied in patients with MDS who also have a low platelet count and in the largest study, it was found that romiplostin did improve platelet counts in about 40 to 50% of MDS patients with low platelet counts.  ...

    Interview last updated 02/07/2013 - 1:28pm.

  6. Dr. Vivienne Rebel reports on a study of the relationship between gene mutations and overall survival after stem cell transplant

    ... Clinical parameters, such as blast counts and platelet counts, are important indicators of the severity of MDS and thus ...

    Research Review last updated 05/02/2016 - 9:16am.

  7. Blood Transfusions: Everything You Need To Know

    ... The difference between red blood cell , platelet and plasma transfusions.  Possible side-effects you may ...

    LMS Item last updated 06/10/2016 - 1:24pm.

  8. Interviews with the Experts: Hemolysis in PNH and Beyond

    ... features of bone marrow failure such as low platelet or neutrophil count. Most patients with PNH develop anemia ...

    Interview last updated 08/31/2016 - 8:40am.

  9. Phase I, Dose Escalation Study of Decitabine

    ... and Lansky scores for patients ≤ 16 years of age; Platelet count ≥ 50,000 (untransfused); Absolute neutrophil ...

    Clinical Trial last updated 06/06/2016 - 9:44am.

  10. Effectiveness of lenalidomide in patients over 75 vs. patients under 75 with RBC transfusion-dependent low/int-1-risk MDS and del5q

    ... neutrophil count) and thrombocytopenia (low platelet count).   These low blood counts can lead to infectious or ... were more likely to require dose-reductions related to low platelet counts.  An increased rate of infections is the most notable safety ...

    Research Review last updated 05/02/2016 - 9:32am.